Product NDC: | 63323-174 |
Proprietary Name: | Ifosfamide |
Non Proprietary Name: | IFOSFAMIDE |
Active Ingredient(s): | 50 mg/mL & nbsp; IFOSFAMIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-174 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090181 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090930 |
Package NDC: | 63323-174-60 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-174-60) > 60 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 63323-174-60 |
Proprietary Name | Ifosfamide |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-174-60) > 60 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 63323-174 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | IFOSFAMIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090930 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | IFOSFAMIDE |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |